These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 373337)

  • 1. [Interrelationships between the virulence and the presence of M-protein in hemolytic streptococcus group A].
    Burova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):46-51. PubMed ID: 373337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
    Schmidt KH; Wiesner J; Gerlach D; Reichardt W; Ozegowski JH; Köhler W
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):231-40. PubMed ID: 8275054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model.
    Tarnutzer A; Andreoni F; Keller N; Zürcher C; Norrby-Teglund A; Schüpbach RA; Zinkernagel AS
    Clin Microbiol Infect; 2019 Apr; 25(4):512.e7-512.e13. PubMed ID: 30025835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.
    Chochua S; Metcalf BJ; Li Z; Rivers J; Mathis S; Jackson D; Gertz RE; Srinivasan V; Lynfield R; Van Beneden C; McGee L; Beall B
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in virulence, M protein and IgG Fc receptor activity in a type 12 group A streptococcal strain during mouse passages.
    Burova LA; Christensen P; Grubb R; Jonsson A; Samuelsson G; Schalén C; Svensson ML
    Acta Pathol Microbiol Scand B; 1980 Aug; 88(4):199-205. PubMed ID: 6774593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between the virulence of streptococci for mice and their IgG FcR activity in in vivo experiments].
    Katser EI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jul; (7):22-6. PubMed ID: 2931928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purification of the M protein of group A hemolytic Streptococci and immunological studies on the M proteins].
    Manabe S
    Kumamoto Igakkai Zasshi; 1972 Jan; 46(1):32-44. PubMed ID: 4624617
    [No Abstract]   [Full Text] [Related]  

  • 8. [Identification with the aid of various serological reactions of L forms of streptococci isolated from the live organism].
    Saulauskiené IJ; Rimkunas AJ; Iesmantaité NA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jul; (7):127-31. PubMed ID: 64097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group A streptococci: pathogenesis and immunity.
    Maxted WR
    Soc Appl Bacteriol Symp Ser; 1978; 7():107-25. PubMed ID: 364656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relationship between bacteriocinogenic and non-bacteriocinogenic streptococcal cultures in experiments in vivo].
    Kolesnichenko TG; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):97-101. PubMed ID: 358696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of protein H expression in M1 serotype isolates of Streptococcus pyogenes.
    Smith TC; Sledjeski DD; Boyle MD
    FEMS Microbiol Lett; 2003 Feb; 219(1):9-15. PubMed ID: 12594016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [OF- and anti-OF test systems in microbiological and epidemiologic practice].
    Beliakova IV; Totolian AA
    Vestn Akad Med Nauk SSSR; 1989; (11):54-9. PubMed ID: 2483011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of multifunctional surface binding proteins--a virulence strategy for group A streptococci?
    Boyle MD
    J Theor Biol; 1995 Apr; 173(4):415-26. PubMed ID: 7783451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microtiter indirect hemagglutination procedure for identification of streptococcal M-protein antibodies.
    Zimmerman RA; Mathews J; Wilson E
    Appl Microbiol; 1968 Nov; 16(11):1640-5. PubMed ID: 4881952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential compartmentalization of Streptococcus pyogenes virulence factors and host protein binding properties as a mechanism for host adaptation.
    Kilsgård O; Karlsson C; Malmström E; Malmström J
    Int J Med Microbiol; 2016 Nov; 306(7):504-516. PubMed ID: 27423808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection.
    Ashbaugh CD; Wessels MR
    Infect Immun; 2001 Nov; 69(11):6683-8. PubMed ID: 11598038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The OF characteristics of streptococci group A and immunity to streptococcal infection based on the results of OF and anti-OF tests].
    Krasil'nikov IA; Iontova IM; Beliakova IV; Sobolevskaia AA; Zubov AK; Stepanova TM; Fomina NI; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):26-31. PubMed ID: 2143613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections.
    The Editors
    J Med Microbiol; 2000 Oct; 49(10):849-852. PubMed ID: 11023181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.